CANQ.F Stock Overview
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CanaQuest Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.14 |
| 52 Week High | US$0.44 |
| 52 Week Low | US$0.03 |
| Beta | 0 |
| 1 Month Change | 40.00% |
| 3 Month Change | -22.22% |
| 1 Year Change | -30.00% |
| 3 Year Change | -41.67% |
| 5 Year Change | -12.50% |
| Change since IPO | -91.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| CANQ.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -0.7% |
| 1Y | -30.0% | 11.6% | 22.3% |
Return vs Industry: CANQ.F underperformed the US Pharmaceuticals industry which returned 11.6% over the past year.
Return vs Market: CANQ.F underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| CANQ.F volatility | |
|---|---|
| CANQ.F Average Weekly Movement | 63.4% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CANQ.F's share price has been volatile over the past 3 months.
Volatility Over Time: CANQ.F's weekly volatility has increased from 52% to 63% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Paul Ramsay | canaquest.com |
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
CanaQuest Medical Corp. Fundamentals Summary
| CANQ.F fundamental statistics | |
|---|---|
| Market cap | US$3.00m |
| Earnings (TTM) | -US$800.18k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs CANQ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANQ.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$1.10m |
| Earnings | -CA$1.10m |
Last Reported Earnings
Mar 31, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CANQ.F perform over the long term?
See historical performance and comparison